CLRB - Company ID 0001279704
Cellectar Biosciences, Inc. has filed 1,001 public company documents between 2011 and 2026. The most frequent type is major company event (367 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 4 | Insider trade | 1y ago2025-02-18 | 2025-02-14 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-02-14 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-02-13 | - | View filing |
| 424B3 | 424B3 | 1y ago2025-02-07 | - | View filing |
| EFFECT | EFFECT | 1y ago2025-02-06 | - | View filing |
| CORRESP | Company correspondence | 1y ago2025-02-04 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-02-03 | - | View filing |
| UPLOAD | SEC correspondence | 1y ago2025-02-03 | - | View filing |
| 8-K | Major company event | 1y ago2025-01-31 | 2025-01-30 | View filing |
| S-1 | IPO registration | 1y ago2025-01-29 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-01-27 | - | View filing |
| 8-K | Major company event | 1y ago2025-01-14 | 2025-01-12 | View filing |